China Mammography report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with radiologists and mammography technologists from level 2 and level 3 hospitals in China.
The report covers :
Insights on hospital structure and utilization, physician treatment selection criteria, and reimbursement are delved into.
Physician’s brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others affecting brand usage have been covered.
Future trends such as investment in breakthrough innovations like Navigator 3000A mammography by Sino MDT which is the first digital mammography machine developed in China are expected to be potential disruptors in the market.
Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as NMPA approval of Gittoo CLASS tomosynthesis by IMS Gittoo which is an innovative breast tomosynthesis system are covered in the report.
What’s in it for you?
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
REPORT COST: 5,000 USD
Contact us for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.